Comparison of pre-hospital 600 mg or 900 mg vs. peri-interventional 300 mg clopidogrel in patients with ST-elevation myocardial infarction undergoing primary coronary angioplasty. The Load&Go randomized trial.

作者信息

Ducci Kenneth, Grotti Simone, Falsini Giovanni, Angioli Paolo, Liistro Francesco, Mandò Massimo, Porto Italo, Bolognese Leonardo

机构信息

Cardiovascular and Neurologic Department, San Donato Hospital, Arezzo, Italy.

出版信息

Int J Cardiol. 2013 Oct 12;168(5):4814-6. doi: 10.1016/j.ijcard.2013.07.012. Epub 2013 Aug 3.

DOI:10.1016/j.ijcard.2013.07.012

PMID:23916779

Abstract

摘要

相似文献

Comparison of pre-hospital 600 mg or 900 mg vs. peri-interventional 300 mg clopidogrel in patients with ST-elevation myocardial infarction undergoing primary coronary angioplasty. The Load&Go randomized trial.

Int J Cardiol. 2013 Oct 12;168(5):4814-6. doi: 10.1016/j.ijcard.2013.07.012. Epub 2013 Aug 3.

Antiplatelet effect of thienopyridine (clopidogrel or prasugrel) pretreatment in patients undergoing primary percutaneous intervention for ST elevation myocardial infarction.噻吩吡啶（氯吡格雷或普拉格雷）预处理对行直接经皮冠状动脉介入治疗的 ST 段抬高型心肌梗死患者的抗血小板作用。

Am J Cardiol. 2013 Nov 15;112(10):1551-6. doi: 10.1016/j.amjcard.2013.07.010. Epub 2013 Aug 22.

Impact of Clopidogrel loading dose in patients with chronic kidney disease undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.氯吡格雷负荷剂量对 ST 段抬高型心肌梗死行直接经皮冠状动脉介入治疗的慢性肾脏病患者的影响。

Am J Cardiol. 2012 Dec 1;110(11):1598-606. doi: 10.1016/j.amjcard.2012.07.025. Epub 2012 Aug 28.

Outcome comparison of 600- and 300-mg loading doses of clopidogrel in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: results from the ARMYDA-6 MI (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty-Myocardial Infarction) randomized study.接受直接经皮冠状动脉介入治疗的 ST 段抬高型心肌梗死患者中，600mg 和 300mg 负荷剂量氯吡格雷的疗效比较：来自 ARMYDA-6 MI（经皮冠状动脉介入治疗期间抗血小板治疗减少心肌损伤-心肌梗死）随机研究的结果。

J Am Coll Cardiol. 2011 Oct 4;58(15):1592-9. doi: 10.1016/j.jacc.2011.06.044.

Comparison of 600 versus 300-mg Clopidogrel loading dose in patients with ST-segment elevation myocardial infarction undergoing primary coronary angioplasty.比较 600 毫克与 300 毫克氯吡格雷负荷剂量在接受直接经皮冠状动脉介入治疗的 ST 段抬高型心肌梗死患者中的应用。

Am J Cardiol. 2010 Nov 1;106(9):1208-11. doi: 10.1016/j.amjcard.2010.06.044.

Usefulness of pretreatment with high-dose clopidogrel in patients undergoing primary angioplasty for ST-elevation myocardial infarction.高剂量氯吡格雷预处理对接受ST段抬高型心肌梗死直接血管成形术患者的有效性

Am J Cardiol. 2009 Aug 15;104(4):514-8. doi: 10.1016/j.amjcard.2009.04.013. Epub 2009 Jun 17.

Clopidogrel pretreatment in ST-elevation myocardial infarction patients transferred for percutaneous coronary intervention.氯吡格雷预处理在 ST 段抬高型心肌梗死患者经皮冠状动脉介入治疗中的应用。

Am Heart J. 2010 Jul;160(1):202-7. doi: 10.1016/j.ahj.2010.04.018.

Effect of early, pre-hospital initiation of high bolus dose tirofiban in patients with ST-segment elevation myocardial infarction on short- and long-term clinical outcome.早期、院前给予高剂量替罗非班对 ST 段抬高型心肌梗死患者短期和长期临床结局的影响。

J Am Coll Cardiol. 2010 Jun 1;55(22):2446-55. doi: 10.1016/j.jacc.2009.11.091.

Comparison of 600 versus 300-mg clopidogrel loading dose in patients with ST-segment elevation myocardial infarction undergoing primary coronary angioplasty.

Am J Cardiol. 2011 Feb 15;107(4):641. doi: 10.1016/j.amjcard.2010.11.001.

Effectiveness of in-laboratory high-dose clopidogrel loading versus routine pre-load in patients undergoing percutaneous coronary intervention: results of the ARMYDA-5 PRELOAD (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty) randomized trial.经皮冠状动脉介入治疗患者中实验室高剂量氯吡格雷负荷治疗与常规预负荷治疗的效果比较：ARMYDA-5 PRELOAD（经皮冠状动脉介入治疗期间抗血小板治疗减少心肌损伤）随机试验结果。

J Am Coll Cardiol. 2010 Aug 10;56(7):550-7. doi: 10.1016/j.jacc.2010.01.067.

引用本文的文献

P2Y12 Inhibitor Pretreatment in Non-ST-Segment Elevation Acute Coronary Syndromes Undergoing a Late Invasive Strategy-A Portuguese Multicenter Nationwide Registry Analysis.接受晚期侵入性策略的非ST段抬高型急性冠状动脉综合征患者的P2Y12抑制剂预处理——一项葡萄牙多中心全国性注册研究分析

Biomedicines. 2025 Sep 9;13(9):2212. doi: 10.3390/biomedicines13092212.

STEMI Antithrombotic Therapy: The Evolving Role of P2Y12 Inhibitor Pretreatment in Contemporary Practice.ST段抬高型心肌梗死的抗栓治疗：当代实践中P2Y12抑制剂预处理的不断演变的作用。

Rev Cardiovasc Med. 2024 Nov 21;25(11):416. doi: 10.31083/j.rcm2511416. eCollection 2024 Nov.

Pretreatment with P2Y Receptor Inhibitors in Acute Coronary Syndromes-Is the Current Standpoint of ESC Experts Sufficiently Supported?急性冠状动脉综合征中P2Y受体抑制剂的预处理——欧洲心脏病学会专家的当前观点是否有充分依据？

J Clin Med. 2023 Mar 19;12(6):2374. doi: 10.3390/jcm12062374.

Pre-Hospital Antiplatelet Therapy for STEMI Patients Undergoing Primary Percutaneous Coronary Intervention: What We Know and What Lies Ahead.ST段抬高型心肌梗死患者行直接经皮冠状动脉介入治疗前的抗血小板治疗：已知与未知。

Thromb Haemost. 2021 Dec;121(12):1562-1573. doi: 10.1055/a-1414-5009. Epub 2021 Apr 30.

Meta-analysis Comparing Outcomes of Type 2 Myocardial Infarction and Type 1 Myocardial Infarction With a Focus on Dual Antiplatelet Therapy.比较2型心肌梗死和1型心肌梗死结局并聚焦双联抗血小板治疗的荟萃分析

CJC Open. 2020 Feb 24;2(3):118-128. doi: 10.1016/j.cjco.2020.02.005. eCollection 2020 May.

Achieving the earliest possible reperfusion in patients with acute coronary syndrome: a current overview.实现急性冠状动脉综合征患者尽早再灌注：当前概述

J Intensive Care. 2018 Mar 15;6:20. doi: 10.1186/s40560-018-0285-9. eCollection 2018.

Contemporary Antiplatelet Pharmacotherapy in the Management of Acute Coronary Syndromes.当代抗血小板药物治疗在急性冠状动脉综合征管理中的应用

Curr Treat Options Cardiovasc Med. 2018 Feb 27;20(2):17. doi: 10.1007/s11936-018-0603-5.

Consensus Document of the Italian Association of Hospital Cardiologists (ANMCO), Italian Society of Cardiology (SIC), Italian Association of Interventional Cardiology (SICI-GISE) and Italian Society of Cardiac Surgery (SICCH): clinical approach to pharmacologic pre-treatment for patients undergoing myocardial revascularization procedures.意大利医院心脏病学家协会（ANMCO）、意大利心脏病学会（SIC）、意大利介入心脏病学会（SICI - GISE）和意大利心脏外科学会（SICCH）的共识文件：心肌血运重建术患者的药物预处理临床方法

Eur Heart J Suppl. 2017 May;19(Suppl D):D151-D162. doi: 10.1093/eurheartj/sux010. Epub 2017 May 2.

Benefits and risks of P2Y12 inhibitor preloading in patients with acute coronary syndrome and stable angina.急性冠脉综合征和稳定性心绞痛患者中 P2Y12 抑制剂预负荷的获益和风险。

J Thromb Thrombolysis. 2017 Oct;44(3):303-315. doi: 10.1007/s11239-017-1529-6.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验